| For: | Shelat VG. Improving clinical outcomes of patients with hepatocellular carcinoma: Role of antiviral therapy, conversion therapy, and palliative therapy. World J Gastrointest Oncol 2024; 16(10): 4037-4041 [PMID: 39473946 DOI: 10.4251/wjgo.v16.i10.4037] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v16/i10/4037.htm |
| Number | Citing Articles |
| 1 |
Vishal G. Shelat. Microbial ecology and hepatocellular carcinoma: should a subset be viewed as a microbiome-conditioned malignancy?. Expert Review of Gastroenterology & Hepatology 2026; 20(7) doi: 10.1080/17474124.2026.2687711
|
| 2 |
Shuqiang Jin, Qimeihui Wang, Lingyu Zhu, Dengke Teng, Guoqing Sui, Hui Wang. Dual-modality imaging with CEUS and MRI for early recurrence assessment in hepatocellular carcinoma following combined radiofrequency ablation and transarterial chemoembolization. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1854471
|
| 3 |
Meng-Ran Lang, Ru-Yu Han, Feng-Yi Zhu, Zhi-Hao Wang, Jian-Xin Zhai, Man Luo, Yao-Wei Hu, Chang-Cheng Tao, Ta-Na Siqin, Ji Sun, Zhi-Yu Lu, Jian-Jun Zhao, Jun-Xiang Tong, Xun Wang, Da-Yong Cao, Li-Ming Wang, Wei-Qi Rong, Jian-Xiong Wu, Xuan Meng, Hong-Guang Wang. Prognostic impact of neoadjuvant therapy <i>vs</i> upfront surgery in patients with huge hepatocellular carcinoma undergoing curative resection. World Journal of Gastroenterology 2027; 33(2): 122833 doi: 10.3748/wjg.122833
Abstract(9) |
Core Tip(7) |
Full Article(HTML)(15)
|
Full Article (PDF)-3124K(1)
|
Full Article with Cover (PDF)-3555K(1)
|
Full Article (XML)-156K(1)
|
Audio-692K(0)
|
Peer-Review Report-328K(2)
|
Answering Reviewers-328K(2)
|
Supplementary Material-43K(1)
|
Times Cited (0)
|
Total Visits (141)
|
Open
|
| 4 |
Jian Qiu, Zhenghui Ye, Liyang Zhao, Wei Liu, Shenao Liu, Hongchuan Zhao. Survival benefits and prognostic models of surgical resection versus continued medical treatment in CNLC stage IIb/IIIa hepatocellular carcinoma after meeting resectability criteria following conversion therapy. Frontiers in Oncology 2026; 16 doi: 10.3389/fonc.2026.1958780
|
| 5 |
Zhang-you Guo, Mu-yang Tu, Yin-shan Yang, Ling-xiang Xu, Dan-dan Fan. Nomogram for predicting post-transarterial chemoembolization survival in recurrent patients with hepatitis B virus-associated hepatocellular carcinoma. Scientific Reports 2025; 15(1) doi: 10.1038/s41598-025-26375-5
|